Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
CAT No: 10-101-62
CAS No:107452-89-1
Synonyms/Alias:Ziconotide;Prialt;omega-conotoxin MVIIA;SNX-111;107452-89-1;omega-Conotoxin M VIIA;Ziconotida;omega-Conopeptide MVIIA (Conus);DRG-0250;UNII-7I64C51O16;HSDB 7609;MFCD00145036;150770-63-1;DTXSID60883174;omega-Conotoxin M VIIA (reduced), cyclic (1-16),(8-20),(15-25)-tris(disulfide);7I64C51O16;H-Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cy;omega-Conotoxin mviia, conus magus;Ziconotide [USAN:INN];ziconotidum;o-Conotoxin MVIIA;.omega.-conotoxin m viia;ZICONOTIDE (MART.);GTPL2536;CHEMBL4594214;N02BG08;CHEBI:135912;CHEBI:142406;DTXCID901323852;HY-P0062;AKOS015994641;AC-8938;AT42420;HS-2032;FC110295;omega-Conotoxin MVIIA, >=95% (HPLC);CS-0015087;NS00068028;?-Conotoxin M VIIA Acetate; ?-Conopeptide MVIIA Acetate; Prialt Acetate; SNX 111;;L-Cysteinyl-L-lysylglycyl-L-lysylglycyl-L-alanyl-L-lysyl-L-cysteinyl-L-seryl-L-arginyl-L-leucyl-L-methionyl-L-tyrosyl-L-alpha-aspartyl-L-cysteinyl-L-cysteinyl-L-threonylglycyl-L-seryl-L-cysteinyl-L-arginyl-L-serylglycyl-L-lysyl-L-cysteinamide cyclic (1-16),(8-20),(15-25)-tris(disulfide);
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.